Murae Organisor Ltd.

1.75 -0.03 ▼-1.7%

15 April 2024, 10:19:00 AM
Volume: 12,852

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.earumpharma.com
Market Cap 43.99 Cr.
Enterprise Value(EV) 46.50 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.03 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.38 Trailing Twelve Months Ending 2023-12
Book Value / Share 2.21 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.80 Calculated using Price: 1.78
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 24.71 Cr. 247,111,618 Shares
FaceValue 2
About Murae Organisor Ltd.
The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API's) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Murae Organisor Ltd. Delivery

Delivered Qty
Traded Qty

Murae Organisor Ltd. Performance

1 Day
-1.69%
1 Week
-2.78%
1 Month
-14.22%
3 Month
+12.18%
6 Month
+73.27%
1 Year
-23.91%
2 Year
-70.54%
5 Year
10 Year

Murae Organisor Ltd. Fundamental Ratios

8 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 7.15 11.05 30.94 32.17 17.83 0.61 14.24 11.18
Return on Capital Employed (%) 17.1 21.97 24.94 23.99 17.4 4.23 12.34 11.66
Return on Assets (%) 1.11 1.61 5.98 7.77 6.11 0.28 7.85 6.91

Murae Organisor Ltd. Balance Sheet

Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 2 5 6 14 15 17 19 55
Non Curr. Liab. 0 1 2 3 1 2 0 0 0
Curr. Liab. 7 9 13 15 20 11 12 10 6
Minority Int.
Equity & Liab. 9 11 20 23 36 28 29 29 60
Non Curr. Assets 0 0 0 0 4 1 1 0 0
Curr. Assets 9 11 19 23 32 27 28 28 60
Misc. Exp. not W/O
Total Assets 9 11 20 23 36 28 29 29 60

Murae Organisor Ltd. Profit and Loss

Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 19 23 35 51 55 41 21 14 4
Other Income 0 0 0 0 2 9 8 2 1
Total Income 19 24 36 51 57 50 29 16 5
Total Expenditure -18 -23 -34 -47 -54 -49 -25 -13 -4
PBIDT 1 1 2 3 4 1 3 3 0
Interest 0 -1 -1 -1 -1 -1 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 -1 -1 0 -1 -1 -1
Exceptional Items
PAT 0 0 1 2 2 0 2 2 -1
Adjusted EPS 0 0 0 0 0 0 0 0

Murae Organisor Ltd. Cash Flow

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -7 0 -3 -7 3 0
Cash Fr. Inv. 0 0 0 0 -3 3 0
Cash Fr. Finan. 1 0 7 1 7 3 -3 0
Net Change 0 0 0 0 0 -1 0 0
Cash & Cash Eqvt 0 0 0 0 0 -1 0 0

Murae Organisor Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 70.04 50.21 37.57 0.00 0.00 0.00 0.00 0.00 0.00
Public 29.96 49.79 62.43 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Murae Organisor Ltd. Announcements

Thu, 04 Apr 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for Notice of Extra-Ordinary General Meeting of the Company under the Regulation 47 of SEBI (LODR) Regulation 2015 as per attachment
Thu, 04 Apr 2024
Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Meeting Board of Directors of the Company was held today i.e. Thursday 4th April 2024 at A-1311 Sun West Bank Ashram Road Ashram Road P.O Ahmedabad - 380 009 which commenced at 5:00 P.M. and concluded at 7:00 P.M. inter-alia has considered and approved the Appointment of Ms. Sangita Rajpurohit as Company Secretary and Compliance Officer of the Company w.e.f. 4th April 2024.Further the information required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September 2015 is enclosed herewith as Annexure A.Please take note of the same on your records. Thanking you Yours faithfully
Thu, 04 Apr 2024
Appointment of Company Secretary and Compliance Officer
Intimation of Appointment of Company Secretary of the Company.

Murae Organisor Ltd. Technical Scans

Fri, 12 Apr 2024
Opening at High Opening at High
Opening at Low Opening at Low
Opening at High for 3 days Opening at High for 3 days
Closing Below Previous Low Closing Below Previous Low
Opening at High for 2 Days Opening at High for 2 Days

Murae Organisor Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,413.61 1,525.60 -0.9%
Cipla Ltd. 112,740.74 1,389.25 -0.5%
Dr. Reddy's Laboratories Ltd. 101,499.74 6,007.85 -1.2%
Divi's Laboratories Ltd. 100,325.89 3,747.15 -0.9%
Zydus Lifesciences Ltd. 96,734.30 943.00 -2.0%
Mankind Pharma Ltd. 92,896.46 2,275.00 -2.0%
Apollo Hospitals Enterprise Ltd. 92,081.85 6,347.45 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.48 1,525.60 -0.9%
Cipla Ltd. Consolidated 2023-12 30.40 1,389.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.41 6,007.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-12 72.54 3,747.15 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.53 943.00 -2.0%
Mankind Pharma Ltd. Consolidated 2023-12 53.79 2,275.00 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 116.66 6,347.45 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.92 1,525.60 -0.9%
Cipla Ltd. Consolidated 2023-12 4.35 1,389.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.78 6,007.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-12 7.70 3,747.15 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.13 943.00 -2.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.46 2,275.00 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.63 6,347.45 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,525.60 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,389.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,007.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,747.15 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 943.00 -2.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,275.00 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.45 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.60 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,389.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,007.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,747.15 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 943.00 -2.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,275.00 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.45 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.60 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,389.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,007.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,747.15 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 943.00 -2.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,275.00 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.45 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,525.60 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,389.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,007.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,747.15 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 943.00 -2.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,275.00 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.45 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,525.60 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,389.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,007.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,747.15 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 943.00 -2.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,275.00 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.45 -0.9%

Murae Organisor Ltd. FAQ's

What is Murae Organisor share price?

Can I buy Murae Organisor shares now?

What is the Market Cap of Murae Organisor?

What are the key metrics to analyse Murae Organisor?

What is the 52 Week High and Low of Murae Organisor?

What is the trend of Murae Organisor share price?